Supriya Lifesci.

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "721.45",
    "chg": 38.65,
    "chgp": "5.66%",
    "dir": 1,
    "prev_price": "682.80",
    "mcapval": "5,806.43 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE07RO01027",
    "curr_date": "May 19",
    "curr_time": "",
    "bse_nse_vol": "5.35 lacs",
    "exc_status": "Active",
    "traded_date": "May 19, 2026",
    "traded_date_str": "2026 05 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd Surges 7.35% to Day's High of Rs 734.2 — Outperforms Sector by 6.65 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-high-with-735-surge-on-19-may-2026-3999043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_priceRelatedfactors_3999043.png",
        "date": "2026-05-19 11:01:18",
        "description": "The Sensex rose 0.57% on 19 May 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.35% gain, touching an intraday high of Rs 734.2. This 6.65 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Supriya Lifescience Declines 2.59%: Technical Weakness and Valuation Concerns Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-declines-259-technical-weakness-and-valuation-concerns-shape-the-week-3994134",
        "imagepath": "",
        "date": "2026-05-16 11:03:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.717.55, gains 1.38% despite Sensex decline</p>\n                    <p><strong>12 May:</strong> Downgrade to Sell rating announced; stock plunges 5.76%</p>\n                    <p><strong>13 May:</strong> Technical momentum shift confirmed; mixed indicator signals emerge</p>\n                    <p><strong>15 May:</strong> Week closes at Rs.689.45, down 2.59% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.707.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Supriya Lifescience Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3988929",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_mojoScore_3988929.png",
        "date": "2026-05-13 08:40:44",
        "description": "Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 12 May 2026. This change reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat recent financial performance, and a cautious outlook on its long-term growth prospects."
      },
      {
        "title": "Supriya Lifescience Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3988747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_technicaldot_3988747.png",
        "date": "2026-05-13 08:05:55",
        "description": "Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. The stock’s current price stands at ₹676.25, down 5.76% from the previous close of ₹717.55, reflecting investor caution amid mixed technical signals and a downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Supriya Lifescience Gains 2.25%: Technical Shift and Hold Upgrade Highlight Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-gains-225-technical-shift-and-hold-upgrade-highlight-week-3983016",
        "imagepath": "",
        "date": "2026-05-09 11:04:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 4:</strong> Week opens at Rs.692.20</p>\n                    <p><strong>May 6:</strong> Stock rallies 1.46% amid strong Sensex gains</p>\n                    <p><strong>May 7:</strong> Slight dip of 0.43% as technical signals remain mixed</p>\n                    <p><strong>May 8:</strong> MarketsMOJO upgrades rating to Hold; stock closes at Rs.707.80 (+1.06%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.692.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.707.80</div><div cl..."
      },
      {
        "title": "Supriya Lifescience Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-upgraded-to-hold-by-marketsmojo-on-technical-improvements-3980956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_mojoScore_3980956.png",
        "date": "2026-05-08 08:21:29",
        "description": "Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 7 May 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This reassessment comes amid a backdrop of mixed financial performance but positive technical signals and growing institutional interest, positioning the small-cap pharmaceutical company for cautious optimism."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-market-signals-3980838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_technicaldot_3980838.png",
        "date": "2026-05-08 08:05:22",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a slight dip in the daily price, the stock’s medium-term outlook shows signs of cautious optimism, supported by mixed signals from MACD, RSI, and moving averages."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-sell-3979474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SupriyaLifescie_mojoScore_3979474.png",
        "date": "2026-05-07 10:11:23",
        "description": "Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Surges 7.7% to Day's High of Rs 697.4 — Outperforms Sector by 5.4 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-high-with-771-surge-on-27-apr-2026-3963966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SupriyaLifescie_priceRelatedfactors_3963966.png",
        "date": "2026-04-27 09:46:10",
        "description": "The Sensex advanced 0.6% on 27 Apr 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.71% gain, touching an intraday high of Rs 697.4. This 5.43-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift."
      }
    ],
    "total": 318,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Supriya Lifescience Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L51900MH2008PLC180452</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Prachi Suhas Sathe <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@supriyalifescience.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Krishna Raghunathan <br/> Designation: Chief Financial Officer <br/> EmailId: cfo@supriyalifescience.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Update On Inspection By United States Food & Drug Administration (USFDA)",
      "datetime": "22-Apr-2026",
      "details": "Enclosed herewith Announcement pertaining to update on USFDA.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "11-Apr-2026",
      "details": "Voting Results and Scrutinizers Report for Postal Ballot conducted by the Company are enclosed herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd Surges 7.35% to Day's High of Rs 734.2 — Outperforms Sector by 6.65 Percentage Points

2026-05-19 11:01:18

The Sensex rose 0.57% on 19 May 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.35% gain, touching an intraday high of Rs 734.2. This 6.65 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Supriya Lifescience Declines 2.59%: Technical Weakness and Valuation Concerns Shape the Week

2026-05-16 11:03:02

Key Events This Week

11 May: Stock opens at Rs.717.55, gains 1.38% despite Sensex decline

12 May: Downgrade to Sell rating announced; stock plunges 5.76%

13 May: Technical momentum shift confirmed; mixed indicator signals emerge

15 May: Week closes at Rs.689.45, down 2.59% for the week

Week Open

Rs.707.80

Week Close

Read full news article

Supriya Lifescience Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-05-13 08:40:44

Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 12 May 2026. This change reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat recent financial performance, and a cautious outlook on its long-term growth prospects.

Read full news article

Supriya Lifescience Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-05-13 08:05:55

Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. The stock’s current price stands at ₹676.25, down 5.76% from the previous close of ₹717.55, reflecting investor caution amid mixed technical signals and a downgrade in its Mojo Grade to Sell.

Read full news article

Supriya Lifescience Gains 2.25%: Technical Shift and Hold Upgrade Highlight Week

2026-05-09 11:04:13

Key Events This Week

May 4: Week opens at Rs.692.20

May 6: Stock rallies 1.46% amid strong Sensex gains

May 7: Slight dip of 0.43% as technical signals remain mixed

May 8: MarketsMOJO upgrades rating to Hold; stock closes at Rs.707.80 (+1.06%)

Week Open

Rs.692.20

Week Close

Rs.707.80

Read full news article

Supriya Lifescience Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements

2026-05-08 08:21:29

Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 7 May 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This reassessment comes amid a backdrop of mixed financial performance but positive technical signals and growing institutional interest, positioning the small-cap pharmaceutical company for cautious optimism.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-08 08:05:22

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a slight dip in the daily price, the stock’s medium-term outlook shows signs of cautious optimism, supported by mixed signals from MACD, RSI, and moving averages.

Read full news article

Supriya Lifescience Ltd is Rated Sell

2026-05-07 10:11:23

Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Supriya Lifescience Ltd Surges 7.7% to Day's High of Rs 697.4 — Outperforms Sector by 5.4 Percentage Points

2026-04-27 09:46:10

The Sensex advanced 0.6% on 27 Apr 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.71% gain, touching an intraday high of Rs 697.4. This 5.43-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

View All News